Table 3.
Variables | Pfa | Pvb | Mixed infection | P-value | ||
---|---|---|---|---|---|---|
Pf vs Pv | Pf vs Mixed infection | Pv vs Mixed infection | ||||
N | 42 | 26 | 58 | |||
Agec | 31.31 ± 13.22 | 31.10 ± 10.64 | 30.52 ± 10.02 | 0.951 | 0.867 | 0.863 |
Sex (*M/F)d | 75.0/25.0 | 68.4/31.60 | 67.6/32.40 | 0.253 | 0.320 | 1.000 |
Infection historye | ||||||
First infection (yes/no) | 81.2/18.8 | 55.6/44.4 | 57.6/42.4 | 0.008 | 0.035 | 0.989 |
Genomic Ancestryf,g | ||||||
European | 0.529 ± 0.299 | 0.583 ± 0.272 | 0.587 ± 0.259 | 0.561 | 0.373 | 0.980 |
African | 0.242 ± 0.231 | 0.137 ± 0.169 | 0.161 ± 0.175 | 0.030 | 0.048 | 0.289 |
Native American | 0.235 ± 0.169 | 0.267 ± 0.169 | 0.263 ± 0.189 | 0.283 | 0.301 | 0.745 |
Pfa, The data are shown as mean ± standard deviation
Plasmodium falciparum; Pvb, Plasmodium vivax; Student’s t-testc; Pearson’s chi-squared testd; Fisher’s exact teste; Mann–Whitney testf; *M, male; F, female. The values highlighted in bold are statistically significant. The proportions of genomic ancestry were estimated using the STRUCTURE softwareg